What does Medexon do?

Medexon is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”, a code that says little about what the company actually does. Private Limited, started on 21 February 2020, 2 establishments.

What is the address of Medexon?

The registered office of Medexon is located at Wetenschapspark 1, 8400 Oostende.

Is Medexon still active?

Yes. According to the CBE (29 October 2026) Medexon is active, legal situation “Normale toestand”, started on 21 February 2020.

Is Medexon registered on Peppol?

Yes, Medexon is registered on the Peppol network with ID 0208:0743962284.

What is the enterprise number of Medexon?

The enterprise number of Medexon is BE0743962284.

When was Medexon founded?

Medexon was founded on 21 February 2020.

Who are the directors of Medexon?

According to the 2025 annual accounts, the directors of Medexon are: MDX-SOLUTIONS BV, Martine Degroote, NAUTICON BV, GENIUS FORUM CV.

Is Medexon a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 February 2020; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account; 2 establishments in the CBE.

How much profit did Medexon make in 2025?

Medexon recorded a loss after taxes of € 29,670 in financial year 2025.

What is the revenue of Medexon?

As a small company, Medexon is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 38,251.

Does Medexon have a website?

Yes, Medexon has a website at medexon.com.

Medexon (Private Limited) - Oostende - BE0743962284

Dossier Medexon, printed on 29 October 2026 from databakkes.be/en/0743962284/medexon. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Busy address KBO

10 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

Medexon from Oostende, company number BE0743962284, closed financial year 2025 with a result of € -29,670 after tax. For that financial year Medexon recorded a gross margin of € 38,251 and equity of € 259,899. Compared with financial year 2024, the result moved from € -18,766 to € -29,670. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 20, 2026.

What it is worth Healthy

€ 259,899

▼ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -29,670

▼ 58 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 127,311

▼ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -10,101.

People and assets in 2025

Vehicles and equipment

€ 35,921

▼ 15% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 137,738

▼ 25% vs 2024

€ 43,948 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 29,387

▼ 40% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 78,064 Gross margin 2022: € 78,064 First fiscal year in the series	€ 50,010 Gross margin 2023: € 50,010 ▼ 36% vs 2022 (€ 78,064) Unfavourable step	€ 31,819 Gross margin 2024: € 31,819 ▼ 36% vs 2023 (€ 50,010) Unfavourable step	€ 38,251 Gross margin 2025: € 38,251 ▲ 20% vs 2024 (€ 31,819) Favourable step	▲ 20%
Profit after taxes	€ 43,541 Profit after taxes 2022: € 43,541 First fiscal year in the series	€ 3,977 Profit after taxes 2023: € 3,977 ▼ 91% vs 2022 (€ 43,541) Unfavourable step	€ -18,766 Profit after taxes 2024: € -18,766 ▼ € 22,743 vs 2023 (€ 3,977) Unfavourable step	€ -29,670 Profit after taxes 2025: € -29,670 ▼ € 10,903 vs 2024 (€ -18,766) Unfavourable step	▼ € 10,903
Equity	€ 54,358 Equity 2022: € 54,358 First fiscal year in the series	€ 58,335 Equity 2023: € 58,335 ▲ 7% vs 2022 (€ 54,358) Favourable step	€ 289,569 Equity 2024: € 289,569 ▲ € 231,234 vs 2023 (€ 58,335) Favourable step	€ 259,899 Equity 2025: € 259,899 ▼ 10% vs 2024 (€ 289,569) Unfavourable step	▼ 10%
Total debts	€ 161,543 Total debts 2022: € 161,543 First fiscal year in the series	€ 161,115 Total debts 2023: € 161,115 Unchanged (€ 161,543) Favourable step	€ 233,406 Total debts 2024: € 233,406 ▲ 45% vs 2023 (€ 161,115) Unfavourable step	€ 167,126 Total debts 2025: € 167,126 ▼ 28% vs 2024 (€ 233,406) Favourable step	▼ 28%
Cash	€ 29,838 Cash 2022: € 29,838 First fiscal year in the series	€ 25,106 Cash 2023: € 25,106 ▼ 16% vs 2022 (€ 29,838) Unfavourable step	€ 193,567 Cash 2024: € 193,567 ▲ € 168,461 vs 2023 (€ 25,106) Favourable step	€ 127,311 Cash 2025: € 127,311 ▼ 34% vs 2024 (€ 193,567) Unfavourable step	▼ 34%
Retained profit	€ 34,358 Retained profit 2022: € 34,358 First fiscal year in the series	€ 38,335 Retained profit 2023: € 38,335 ▲ 12% vs 2022 (€ 34,358) Favourable step	€ 19,569 Retained profit 2024: € 19,569 ▼ 49% vs 2023 (€ 38,335) Unfavourable step	€ -10,101 Retained profit 2025: € -10,101 ▼ € 29,670 vs 2024 (€ 19,569) Unfavourable step	▼ € 29,670
Bank debt	€ 103,473 Bank debt 2022: € 103,473 First fiscal year in the series	€ 107,853 Bank debt 2023: € 107,853 ▲ 4% vs 2022 (€ 103,473) Unfavourable step	€ 184,673 Bank debt 2024: € 184,673 ▲ 71% vs 2023 (€ 107,853) Unfavourable step	€ 137,738 Bank debt 2025: € 137,738 ▼ 25% vs 2024 (€ 184,673) Favourable step	▼ 25%
Balance sheet total	€ 215,902 Balance sheet total 2022: € 215,902 First fiscal year in the series	€ 219,450 Balance sheet total 2023: € 219,450 ▲ 2% vs 2022 (€ 215,902) Unchanged	€ 522,975 Balance sheet total 2024: € 522,975 ▲ 138% vs 2023 (€ 219,450) Unchanged	€ 427,025 Balance sheet total 2025: € 427,025 ▼ 18% vs 2024 (€ 522,975) Unchanged	▼ 18%

Key figures of Medexon, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Medexon?

What happened at Medexon in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 20, 2026 New annual accounts for financial year 2025: loss of € 29,670. Source: NBB ↗
2025 NAUTICON BV stepped down as director. NBB
2025 GENIUS FORUM CV stepped down as director. NBB
Oct 11, 2024 New establishment in Oostende. KBO
Feb 21, 2020 New establishment in Zedelgem. KBO
Feb 21, 2020 Start of the company according to the CBE. KBO

In short

From € 43,541 profit in 2022 to € 29,670 loss in 2025.

Paid € 5,573 in corporate taxes since 2022.

Best year ever: 2022, with € 43,541 profit.

Original PDFs at the National Bank ↗

Management

Genius Forum 15.4%

The stake of Genius Forum comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Medexon

Behind Medexon are MDX-SOLUTIONS BV and Martine Degroote. The shares are held by Genius Forum (15.4%).

Directors

According to the 2025 annual accounts

MDX-SOLUTIONS BV

Director · represented by Dirk Caestecker

Martine Degroote

Director

Also active at: MDX-Solutions

NAUTICON BV

Director · represented by Roeland Zwaenepoel

Also active at: Genius Forum

· until 2025

GENIUS FORUM CV

Director · represented by Dirk Roelens

Also active at: Fo Le Fer

· until 2025

Shareholders

Genius Forum

15.4%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Wetenschapspark 1

8400 Oostende

2.300.127.544

Hof van Steelant 11

8210 Zedelgem

Active since 21 February 2020

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.

All companies at this address →

UXSOlutions

€ 144,259 gross margin · 2025

BOC - Belgian Offshore Cluster

Blue Power Synergy

€ 42,950 gross margin · 2025

De Blauwe Cluster (Blue Cluster)

€ 1.1 million gross margin · 2025

OSTEND SCIENCE PARK

€ -66,882 gross margin · 2025

+5 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS medexon.com

About

Technologies

ApacheComplianzElementorFont AwesomeGoogle FontsPHPSwiperTranslatePressWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

AS-ZXCS, NL

Domain

medexon.com

Registered

2009-07-24

Registrar

Combell NV

Expires

2026-07-24

Website info

HTTPS Ja

Languages EN, NL

Features

Webshop Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number: 0743.962.284
VAT number: BE 0743.962.284
Registered office: Wetenschapspark 1, 8400 Oostende
Names & denominations: Medexon
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 February 2020
Peppol: Active · Active since 3 Sept 2026
Contact: medexon.com [email protected] 0470693103
Activities · NACE: Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗